Alchemist AI vs Enzyme — how do they compare? Alchemist AI trades at Rp472.05 (market cap Rp403,26M, Rp40,54M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Alchemist AI is far larger — about 3× Enzyme's market cap, and Alchemist AI's supply is capped (850M / 1B ALCH (85%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Alchemist AI for 6 Days and Enzyme for 29 Days on average.
| ALCH | MLN | |
|---|---|---|
Market Cap | Rp403,26M | Rp134,13M |
Volume (24h) | Rp40,54M | Rp104,56M |
Circulating Supply | 850M / 1B ALCH (85%) | 3,3M MLN |
Typical Hold Time | 6 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
ALCH is trading at Rp481.6 with a bearish technical signal, showing resistance near Rp487 and support at Rp477. The token has 85% of its 1M max supply in circulation, with an average hold time of 6 days. No major protocol updates or ecosystem news were reported recently, indicating limited fundamental catalysts.
Overall outlook remains cautious due to strong bearish momentum and low liquidity. Key opportunities include potential rebounds from support levels, while major risks involve high volatility and thin trading volumes. Investors should monitor for any ecosystem developments to gauge recovery potential.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Alchemist AI is a no-code development platform that enables users to turn any idea, dream, or thought into a functional application.
Read more on ALCH →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →